Stale bread and reheated leftovers: 4-year update of the evolut low risk trial
Commentary on a reanalysis of the 4-year results from the Evolut Low Risk trial, excluding Abbott/St. Jude Trifecta prostheses from the surgical cohort.
Heart Surgery Today
Myocardial viability before revascularization: does it make a difference?
This retrospective single-center study assessed the impact of quantifying myocardial viability, using FDG-PET and cardiac magnetic resonance imaging (CMR), prior to surgical coronary revascularization in patients with left ventricular dysfunction.
Does it make sense to revascularize occluded vessels? Seeking for clarity
Subanalysis of the REGROUP trial assessing 5-year outcomes after surgical revascularization in patients with at least one totally occluded coronary vessel versus those without any occlusions.
When to intervene in aortic regurgitation: practical recommendations according to the 2021 esc/eacts guidelines
This summary updates the indications for intervention in aortic regurgitation (AR) according to the 2021 ESC/EACTS guidelines, with a practical and clinically oriented perspective.
Repair or replace? critical decisions after failed Mitraclip®
The international multicenter CUTTING-EDGE registry investigates surgical strategies and outcomes in patients undergoing conventional surgery after failed mitral transcatheter edge-to-edge repair (M-TEER).
Randomized clinical trials in cardiac surgery: from necessity to difficulty
A commentary on a review article exploring the current state of randomized evidence and its role in advancing cardiac surgery.
Surgeons under scrutiny: the 360° revolution in the U.S. versus inertia in the Spanish model
The American Board of Thoracic Surgery (ABTS) has formally adopted the 360° evaluation as an integral component of its certification process for thoracic surgeons, aiming to provide a more objective assessment of professional competence and nontechnical skills.
Hypoplastic left heart syndrome: “and miles to go before I sleep”
Expert review on the current status and historical evolution of hypoplastic left heart syndrome (HLHS).
Extracorporeal circulation and cancer risk: what does the new evidence tell us?
This Swedish retrospective observational study compares the long-term risk of cancer incidence in relation to the use or omission of cardiopulmonary bypass (CPB) during coronary artery bypass grafting (CABG).
Ten-year outcomes of the Epic® porcine valve: is the Abbott® as good as it looks?
This retrospective observational study, based on real-world data, aimed to assess the 10-year outcomes of the St. Jude/Abbott Epic® porcine mitral valve.